# Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China

> **NCT01021904** · PHASE4 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 6200 (estimated)

## Conditions studied

- HPV Infections
- Precancerous Disease of the Cervix
- Cervical Cancer
- HPV Related Diseases

## Interventions

- **BIOLOGICAL:** Gardasil (VLP, HPV Quadrivalent prophylactic vaccine)

## Key facts

- **NCT ID:** NCT01021904
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-12
- **Target enrollment:** 6200 (ESTIMATED)
- **Last updated:** 2009-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01021904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01021904, "Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01021904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*